Detail akcie Dr. Martens Rg online

Business Summary: Dr. Martens plc is a United Kingdom-based company, which designs, develops, procures, markets, sells and distributes footwear, under the Dr. Martens brand. The Company’s segments include Europe, the Middle East and Africa (EMEA); Americas; and Americas and Asia-Pacific (APAC). Its product segments include boots, shoes, sandals, and bags & other. Its boots offerings include the 1460 8-eye boot, 2976 Chelsea boot, Jadon, Bex and Sinclair. Its shoes offerings include 1461 3-eye shoe and the Adrian tassel loafer, as well as franchises/families such as Buzz and Lowell. Its sandals range includes Blaire and Gryphon silhouettes and also includes the mules range, led by the Zebzag. Its bag range is focused on key silhouettes of leather bags, such as the Kiev backpack, the heart-shaped bag and its weekender bag. This category also includes socks, laces and shoe care. The Company offers its products through direct-to-consumer channel via its ecommerce platforms and its stores, among others.
Financial Summary: BRIEF: For the 26 weeks ended 28 September 2025, Dr Martens PLC revenues decreased 1% to L322M. Net loss decreased 52% to L10M. Revenues reflect EMEA segment decrease of 2% to L158.6M, EMEA segment decrease of 2% to L158.6M, Online Sales - Total decrease of 7% to L81.3M. Lower net loss reflects Selling and administrative expenses decrease of 17% to L146.8M (expense). Dividend per share remained flat at L0.01.